Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1380312 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Yao Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, Ch…. Hauptthemen laut MEDLINE: Tetracyclines, Anti-Bacterial Agents, Legionnaires' Disease, Legionella pneumophila. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Legionella , one of the main pathogens that causes community-acquired pneumonia, can lead to Legionella pneumonia , a condition characterized predominantly by severe pneumonia. This disease, caused by the bacterium Legionella pneumophila , can quickly progress to critical pneumonia and is often associated with damage to multiple organs. As a result, it requires close attention in terms of clinical diagnosis and treatment. Omadacycline, a new type of tetracycline derivative belonging to the aminomethylcycline class of antibiotics, is a semi-synthetic compound derived from minocycline. Its key structural feature, the aminomethyl modification, allows omadacycline to overcome bacterial resistance and broadens its range of effectiveness against bacteria. Clinical studies have demonstrated that omadacycline is not metabolized in the body, and patients with hepatic and renal dysfunction do not need to adjust their dosage. This paper reports a case of successful treatment of Legionella pneumonia with omadacycline in a patient who initially did not respond to empirical treatment with moxifloxacin. The patient also experienced electrolyte disturbance, as well as dysfunction in the liver and kidneys, delirium, and other related psychiatric symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Second Xiangya Hospital, Central South University, Institute of Clinical Pharmacy, Central South University, Changsha, China.
- Department of Pharmacy, Traffic Hospital of Hunan Province, Changsha, China.
- Department of Chemistry and Bioengineering, Yichun University, Yichun, China.
- Department of Pharmacy, Foresea Life Insurance Shaoguan Hospital, Shaoguan, China.
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
- Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China.
Zitieren
APA
Wang, Y., Yi, S. M., Huang, S. M., Xu, W. X., Wei, Y. W., Qu, Q., & Qu, J. (2024). Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1380312
Vancouver
Wang Y, Yi SM, Huang SM, Xu WX, Wei YW, Qu Q, et al. Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1380312
BibTeX
@article{Wang2024,
author = {Wang, Yao and Yi, Shui-Min and Huang, Si-Min and Xu, Wei-Xin and Wei, Yi-Wen and Qu, Qiang and Qu, Jian},
title = {Efficacy of omadacycline in the treatment of Legionella pneumonia: a case report},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1380312}
}
EUVIMED